LEQEMBI now set to launch in Japan for Alzheimer’s disease
TOKYO: Swedish firm BioArctic AB’s partner Eisai has announced that LEQEMBI (lecanemab) will be launched
TOKYO: Swedish firm BioArctic AB’s partner Eisai has announced that LEQEMBI (lecanemab) will be launched